CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.